Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
about
The MYC oncogene is a global regulator of the immune response.Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer.MEK inhibitors for the treatment of NRAS mutant melanomaThe intracellular signalosome of PD-L1 in cancer cellsTumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune EvasionBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsAutochthonous murine models for the study of smoker and never-smoker associated lung cancers
P2860
Q52728139-17FFB78D-CD5C-431B-93BD-12C51839D263Q55100565-2B4D8C10-C772-42EB-ABFD-273E45C91816Q55264112-77A8A67F-C91D-464C-9C07-ABCEF4509958Q56889985-25AC06A7-CD44-4098-90D5-4A9B292FDF70Q57067759-CBF85588-3574-413C-8267-D57C4C8C4544Q57072897-3DEBAAA4-A602-4E4A-ADB2-868024F35199Q58713932-C3CA4C09-8734-478B-BE97-D71835A9EB1EQ58804389-ABD0CFFE-4D48-4FF3-8EAD-51B388C700CE
P2860
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@en
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@nl
type
label
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@en
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@nl
prefLabel
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@en
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
@nl
P2093
P2860
P50
P1433
P1476
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
@en
P2093
Bradley Spencer-Dene
Christopher Moore
Davide Zecchin
Karin Barnouin
Perry J Blackshear
Philip East
Sareena Rana
P2860
P304
1083-1099.e6
P356
10.1016/J.IMMUNI.2017.11.016
P407
P577
2017-12-12T00:00:00Z